{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:16:20Z","timestamp":1790381780630,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Coccidioidal meningitis (CM) is the most severe form of disseminated coccidioidomycosis. Despite years of clinical experience, it remains a difficult condition to treat, often requiring surgical procedures, such as placement of a ventriculoperitoneal shunt, in addition to lifelong antifungal therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective analysis of patients with CM seen in a large referral center in Central Valley, California, from 2010 to 2020. Data pertinent to CM were collected and analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 133 patients with CM identified in the 10-year period, nonadherence to antifungal therapy was noted in 43% of patients. Of the 80 patients who underwent ventriculoperitoneal shunt placement for management of intracranial pressure, shunt failure requiring revision surgery occurred in 42 (52.5%). Rehospitalizations due to CM-related reasons occurred in 78 of 133 patients (59%). Twenty-three percent of patients (n = 29) died due to complications from CM, on an average 22 months after the diagnosis of CM. Encephalopathy at presentation was associated with a significantly higher risk of death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with CM in central California are predominantly rural agricultural workers with elevated levels of poverty and low health literacy and many barriers to care, leading to high rates of medication nonadherence and loss to follow-up outpatient care. Management challenges are frequent, such as failure of antifungal therapy, high rates of rehospitalization, and the need for repeated shunt revision surgeries. In addition to the development of curative new antifungal agents, understanding the barriers to patient adherence to care and antifungal therapy and identifying means to overcome such barriers are of paramount importance.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofad243","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T07:05:31Z","timestamp":1683011131000},"source":"Crossref","is-referenced-by-count":17,"title":["Challenges in the Long-term Management of Patients With Coccidioidal Meningitis: A Retrospective Analysis of Treatment and Outcomes"],"prefix":"10.1093","volume":"10","author":[{"given":"Geetha","family":"Sivasubramanian","sequence":"first","affiliation":[{"name":"Division of Infectious Disease, University of California, San Francisco , Fresno, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurin","family":"Kadakia","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of California, San Francisco , Fresno, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani M","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, University of California, San Francisco , Fresno, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Pervaiz","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, University of California, San Francisco , Fresno, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqi","family":"Yan","sequence":"additional","affiliation":[{"name":"HSRI Biostatistics and Data Support Core, University of California , Merced, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Libke","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, University of California, San Francisco , Fresno, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"2023061518293103700_ofad243-B1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.idc.2021.03.010","article-title":"Coccidioidomycosis","volume":"35","author":"Bays","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"2023061518293103700_ofad243-B2","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/ijerph8041150","article-title":"The public health impact of coccidioidomycosis in Arizona and California","volume":"8","author":"Hector","year":"2011","journal-title":"Int J Environ Res Public Health"},{"key":"2023061518293103700_ofad243-B3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/jof8040413","article-title":"Current landscape of coccidioidomycosis","volume":"8","author":"Boro","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2023061518293103700_ofad243-B4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1086\/319203","article-title":"Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995\u20131996","volume":"32","author":"Rosenstein","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2023061518293103700_ofad243-B5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/jof5030054","article-title":"Central nervous system infections due to coccidioidomycosis","volume":"5","author":"Jackson","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"2023061518293103700_ofad243-B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11910-018-0824-8","article-title":"Coccidioidal meningitis: a review on diagnosis, treatment, and management of complications","volume":"18","author":"Johnson","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2023061518293103700_ofad243-B7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3171\/2014.6.JNS14111","article-title":"Patient outcomes and surgical complications in coccidioidomycosis-related hydrocephalus: an institutional review","volume":"121","author":"Hardesty","year":"2014","journal-title":"J Neurosurg"},{"key":"2023061518293103700_ofad243-B8","first-page":"519","article-title":"Intrathecal amphotericin B: a 60-year experience in treating coccidioidal meningitis","volume":"64","author":"Ho","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2023061518293103700_ofad243-B9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11046-017-0240-7","article-title":"Liposomal amphotericin B as monotherapy in relapsed coccidioidal meningitis","volume":"183","author":"Stewart","year":"2018","journal-title":"Mycopathologia"},{"key":"2023061518293103700_ofad243-B10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/cid\/ciw538","article-title":"Executive summary: 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2023061518293103700_ofad243-B11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-119-1-199307010-00005","article-title":"Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group","volume":"119","author":"Galgiani","year":"1993","journal-title":"Ann Intern Med"},{"key":"2023061518293103700_ofad243-B12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-124-3-199602010-00004","article-title":"Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?","volume":"124","author":"Dewsnup","year":"1996","journal-title":"Ann Intern Med"},{"key":"2023061518293103700_ofad243-B13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/jamaneurol.2013.1139","article-title":"Recurrence of coccidioidal meningitis after discontinuation of fluconazole","volume":"70","author":"Nelson","year":"2013","journal-title":"JAMA Neurol"},{"key":"2023061518293103700_ofad243-B14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/JCM.02731-14","article-title":"Development of a real-time PCR assay for identification of Coccidioides immitis by use of the BD Max system","volume":"53","author":"Mitchell","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2023061518293103700_ofad243-B15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MD.0b013e3181f378a8","article-title":"Coccidioidal meningitis: clinical presentation and management in the fluconazole era","volume":"89","author":"Mathisen","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"2023061518293103700_ofad243-B16","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.0b013e3181c34b69","article-title":"Coccidioidal meningitis and brain abscesses: analysis of 71 cases at a referral center","volume":"73","author":"Drake","year":"2009","journal-title":"Neurology"},{"key":"2023061518293103700_ofad243-B17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3201\/eid2607.200024","article-title":"Risk for coccidioidomycosis among Hispanic farm workers, California, USA, 2018","volume":"26","author":"McCurdy","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2023061518293103700_ofad243-B18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159491","article-title":"Immunogenetics associated with severe coccidioidomycosis","volume":"7","author":"Hsu","year":"2022","journal-title":"JCI Insight"},{"key":"2023061518293103700_ofad243-B19","first-page":"339","article-title":"Coccidioidal meningitis. The use of amphotericin B in treatment","volume":"94","author":"Einstein","year":"1961","journal-title":"Calif Med"},{"key":"2023061518293103700_ofad243-B20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80371-4","article-title":"Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group","volume":"98","author":"Catanzaro","year":"1995","journal-title":"Am J Med"},{"key":"2023061518293103700_ofad243-B21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinids\/18.3.470","article-title":"Itraconazole and fluconazole for treatment of coccidioidomycosis","volume":"18","author":"Stevens","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2023061518293103700_ofad243-B22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/jof8111157","article-title":"Fluconazole failure in the treatment of coccidioidal meningitis","volume":"8","author":"Gupta","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"2023061518293103700_ofad243-B23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3201\/eid0804.010103","article-title":"Biofilm on ventriculo-peritoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis","volume":"8","author":"Davis","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"2023061518293103700_ofad243-B24","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/j.wneu.2020.03.135","article-title":"Shunt treatment for coccidioidomycosis-related hydrocephalus: a single-center series","volume":"138","author":"Morshed","year":"2020","journal-title":"World Neurosurg"},{"key":"2023061518293103700_ofad243-B25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00999-18","article-title":"The orotomide olorofim is efficacious in an experimental model of central nervous system coccidioidomycosis","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2023061518293103700_ofad243-B26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad243\/50152705\/ofad243.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/6\/ofad243\/50620918\/ofad243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/6\/ofad243\/50620918\/ofad243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T18:36:10Z","timestamp":1686854170000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad243\/7147607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad243","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2023,5,2]]},"article-number":"ofad243"}}